On Nov. 3, 2020, Medigen Vaccine Biologics (MVC) and the National Institute of Hygiene and Epidemiology (NIHE), a public institute under the Ministry of Health in Vietnam, entered a partnership in MVC-COV1901 vaccine development.

MVC conducted the clinical trials of MVC-COV1901 vaccine in Vietnam, whereas NIHE provided medical expertise to support the clinical studies and BLA registration via Emergency Usage Authorization route in accordance to Vietnam regulations.